Nanocolloidal carriers of isotretinoin: Antimicrobial activity against propionibacterium acnes and dermatokinetic modeling

Molecular Pharmaceutics

Volumn 10, Issue 5, 2013, Pages 1958-1963

  Raza, Kaisar ^a   Singh, Bhupinder ^a,b   Singla, Saloni ^a   Wadhwa, Sheetu ^b   Garg, Babita ^b   Chhibber, Sanjay ^a   Katare, Om Prakash ^b  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

acne vulgaris; anaerobic pathogen; comedolytic; minimum inhibitory concentration (MIC); nanolipid carriers (NLCs); Propionibacterium acnes; solid lipid nanoparticles (SLNs)

Indexed keywords

CLINDAMYCIN PHOSPHATE; ISOTRETINOIN; NANOCARRIER; SOLID LIPID NANOPARTICLE; ANTIINFECTIVE AGENT; DERMATOLOGICAL AGENT; DRUG CARRIER; LIPID; NANOCAPSULE; NANOPARTICLE;

ADHESION; ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; BROTH DILUTION; CONTROLLED STUDY; DRUG RELEASE; DRUG TRANSPORT; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; RAT; ACNE VULGARIS; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; DRUG EFFECTS; HAIRLESS MOUSE; HUMAN; METABOLISM; MICROBIOLOGY; MOUSE; PATHOGENICITY; PERMEABILITY; SKIN; ULTRASTRUCTURE; WISTAR RAT;

ACNE VULGARIS; ANIMALS; ANTI-INFECTIVE AGENTS; DERMATOLOGIC AGENTS; DRUG CARRIERS; HUMANS; ISOTRETINOIN; LIPIDS; MALE; MICE; MICE, HAIRLESS; MODELS, BIOLOGICAL; NANOCAPSULES; NANOPARTICLES; PERMEABILITY; PROPIONIBACTERIUM ACNES; RATS; RATS, WISTAR; SKIN;

EID: 84877276974     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300722f     Document Type: Article

References (31)

1. Raza, K.; Talwar, V.; Setia, A.; Katare, O. P. Acne: An understanding of the disease and its impact on life Int. J. Drug Dev. Res. 2012, 4, 14-20
2. Yang, D.; Pornpattananangkul, D.; Nakatsuji, T.; Chan, M.; Carson, D.; Huang, C. M.; Zhang, L. The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes Biomaterials 2009, 30, 6035-6040
3. Pannu, J.; McCarthy, A.; Martin, A.; Hamouda, T.; Ciotti, S.; Ma, L.; Sutcliffe, J.; Baker, J. R., Jr. In vitro antibacterial activity of NB-003 against Propionibacterium acnes Antimicrob. Agents Chemother. 2011, 55, 4211-4217
4. Leyden, L. L.; McGinley, K. J.; Mills, O. H.; Kligman, A. M. Propionibacterium levels in patients with and without acne vulgaris J. Invest. Dermatol. 1975, 65, 382-384
5. Nakatsuji, T.; Rasochova, L.; Huang, C. M. Vaccine therapy for P. acnes -associated diseases Infect. Disord. Drug Targets 2008, 8, 160-165
6. Golchai, J.; Khani, S. H.; Heidarzadeh, A.; Eshkevari, S. S.; Alizade, N.; Eftekhari, H. Comparison of anxiety and depression in patients with acne vulgaris and healthy individuals Indian J. Dermatol. 2010, 55, 352-354
7. Saising, J.; Voravuthikunchai, S. P. Anti Propionibacterium acnes activity of rhodomyrtone, an effective compound from Rhodomyrtus tomentosa (Aiton) Hassk. leaves Anaerobe 2012, 18, 400-404
8. Stern, R. S. Medication and medical service utilization for acne 1995-1998 J. Am. Acad. Dermatol. 2000, 43, 1042-1048
9. Simonart, T. Newer Approaches to the Treatment of Acne Vulgaris Am. J. Clin. Dermatol. 2012, 13, 357-364
10. Kraft, J.; Freiman, A. Management of acne CMAJ 2011, 183, E430-435
11. Layton, A. M.; Knaggs, H.; Taylor, J.; Cunliffe, W. J. Isotretinoin for acne vulgaris-10 years later: a safe and successful treatment Br. J. Dermatol. 1993, 129, 292-296
12. Fu, L. W.; Vender, R. B. Newer approaches in topical combination therapy for acne Skin Therapy Lett. 2011, 16, 3-6
13. Zeichner, J. A. Optimizing topical combination therapy for the treatment of acne vulgaris J. Drugs Dermatol. 2012, 11, 313-317
14. Kircik, L. Community-based trial results of combination clindamycin 1%-benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne Cutis 2007, 80, 10-14
15. Toyne, H.; Webber, C.; Collignon, P.; Dwan, K.; Kljakovic, M. Propionibacterium acnes (P. acnes) resistance and antibiotic use in patients attending Australian general practice Australas. J. Dermatol. 2012, 53, 106-111
16. Tan, H. H.; Goh, C. L.; Yeo, M. G.; Tan, M. L. Antibiotic sensitivity of Propionibacterium acnes isolates from patients with acne vulgaris in a tertiary dermatological referral centre in Singapore Ann. Acad. Med. Singapore 2001, 30, 22-25
17. Katare, O. P.; Raza, K.; Singh, B.; Dogra, S. Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors Indian J. Dermatol. Venereol. Leprol. 2010, 76, 612-621
18. Silva, A. H.; Filippin-Monteiro, F. B.; Mattei, B.; Zanetti-Ramos, B. G.; Creczynski-Pasa, T. B. In vitro biocompatibility of solid lipid nanoparticles Sci. Total Environ. 2012, 432, 382-388
19. Das, S.; Ng, W. K.; Tan, R. B. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur. J. Pharm. Sci. 2012, 47, 139-151
20. Puri, A.; Loomis, K.; Smith, B.; Lee, J. H.; Yavlovich, A.; Heldman, E.; Blumenthal, R. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic Crit. Rev. Ther. Drug Carrier Syst. 2009, 26, 523-580
21. McBride, M. C.; Malcolm, R. K.; Woolfson, A. D.; Gorman, S. P. Persistence of antimicrobial activity through sustained release of triclosan from pegylated silicone elastomers Biomaterials 2009, 30, 6739-6747
22. Raza, K.; Singh, B.; Singal, P.; Wadhwa, S.; Katare, O. P. Systematically optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acn Colloids Surf., B 2013, 105C, 67-74
23. Raza, K.; Singh, B.; Singla, N.; Negi, P.; Singal, P.; Katare, O. P. Nano-lipoidal carriers of isotretinoin with anti-aging potential: formulation, characterization and biochemical evaluation. J. Drug Target. 2013, 10.3109/1061186X.2012.761224.
24. Unkles, S. E.; Gemmell, C. G. Effect of clindamycin, erythromycin, lincomycin, and tetracycline on growth and extracellular lipase production by propionibacteria in vitro Antimicrob. Agents Chemother. 1982, 21, 39-43
25. Tsai, T.; Wu, W.; Tseng, J.; Tsai, P. In vitro antimicrobial and anti-inflammatory effects of herbs against Propionibacterium acnes Food Chem. 2010, 119, 964-968
26. Diniz, D. G. A.; Alves, C. P. I.; Castro, N. C.; Rodovalho, L. F. F.; Benfica, P. L.; Valadares, M. C. Isotretinoin-containing liposomes: obtention, characterization and in vitro cytotoxicity on leukemia cells Appl. Cancer Res. 2008, 28, 106-111
27. European Pharmacopoeia, European Directorate for the Quality of Medicines. Council of Europe, Strasbourg, France, 2010; pp 2293-2294.
28. Bonina, F. P.; Montenegro, L.; Scrofani, N.; Esposito, E.; Cortesi, R.; Menegatti, E.; Nastruzzi, C. Effect of phospholipid based formulations on in-vitro and in-vivo percutaneous absorption of methyl nicotinate J. Controlled Release 1995, 34, 53-63
29. Fujii, M.; Bouno, M.; Fujita, S.; Yoshida, M.; Watanabe, Y.; Matsumoto, M. Preparation of griseofulvin for topical application using N-methyl-2-pyrrolidone Biol. Pharm. Bull. 2000, 23, 1341-1345
30. Kligman, A. M.; Christophers, E. Preparation of isolated sheets of human stratum corneum Arch. Dermatol. 1963, 88, 702-705
31. Jensen, B. K.; McGann, L. A.; Kachevsky, V.; Franz, T. J. The negligible systemic availability of retinoids with multiple and excessive topical application of isotretinoin 0.05% gel (Isotrex) in patients with acne vulgaris J. Am. Acad. Dermatol. 1991, 24, 425-428